Merck KGaA submits Rebif extention application in Europe

A board to discuss the Multiple Sclerosis modifying drug Rebif

Merck KGaA submits Rebif extention application in Europe

Postby MSUK » Wed Jun 29, 2011 1:55 am

Image

Merck KGaA submitted an application to the European Medicines Agency or EMA to extend the indication of Rebif, its treatment for multiple sclerosis or MS. The company added that the requested label extension is for the use of Rebif in patients who have experienced a single demyelinating event, an early sign of the disease, and who are at high risk of converting to MS..... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1901
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2226
Joined: Wed Oct 14, 2009 2:00 pm

Advertisement

Return to Rebif

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service